Wells Fargo & Company Increases Globe Life (NYSE:GL) Price Target to $172.00

Globe Life (NYSE:GL) had its price objective boosted by stock analysts at Wells Fargo & Company from $171.00 to $172.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential upside of 17.83% from the stock’s previous close.

A number of other equities research analysts have also recently commented on the company. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Weiss Ratings cut Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, March 30th. Piper Sandler upgraded Globe Life to a “strong-buy” rating in a research note on Thursday, April 2nd. Keefe, Bruyette & Woods reiterated a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Globe Life has a consensus rating of “Moderate Buy” and a consensus target price of $172.11.

Globe Life Trading Down 1.0%

NYSE GL opened at $145.98 on Friday. The stock has a market capitalization of $11.45 billion, a price-to-earnings ratio of 10.37 and a beta of 0.47. Globe Life has a one year low of $111.13 and a one year high of $152.71. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The business’s fifty day moving average is $142.37 and its 200-day moving average is $138.83.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The company’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts predict that Globe Life will post 13.87 EPS for the current year.

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 18,318 shares of Globe Life stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the completion of the transaction, the chief executive officer owned 51,093 shares of the company’s stock, valued at $7,413,594.30. The trade was a 26.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Mark A. Blinn sold 1,750 shares of Globe Life stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the transaction, the director directly owned 3,372 shares of the company’s stock, valued at $498,752.52. The trade was a 34.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 82,807 shares of company stock worth $12,041,286. 2.11% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in shares of Globe Life by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Globe Life by 2.7% during the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after purchasing an additional 102,445 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Globe Life by 2.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,135,861 shares of the company’s stock worth $298,732,000 after purchasing an additional 59,629 shares in the last quarter. Morgan Stanley grew its holdings in shares of Globe Life by 7.2% during the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock worth $260,176,000 after purchasing an additional 125,567 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of Globe Life by 32.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock worth $200,734,000 after purchasing an additional 355,399 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.